Cargando…

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms

Detalles Bibliográficos
Autores principales:	Campana, Raffaela, Marth, Katharina, Zieglmayer, Petra, Weber, Milena, Lupinek, Christian, Zhernov, Yury, Elisyutina, Olga, Khaitov, Musa, Rigler, Eva, Westritschnig, Kerstin, Berger, Uwe, Wolkersdorfer, Martin, Horak, Fritz, Horak, Friedrich, Valenta, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411133/ https://www.ncbi.nlm.nih.gov/pubmed/30471304 http://dx.doi.org/10.1016/j.jaci.2018.11.011

Ejemplares similares

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

NMR resonance assignments of a hypoallergenic isoform of the major birch pollen allergen Bet v 1
por: Ahammer, Linda, et al.
Publicado: (2017)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Trimolecular complex between major birch pollen allergen, Bet v 1, monoclonal allergen-specific human IgE and recombinant CD23
por: Selb, Regina, et al.
Publicado: (2014)

Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
por: Klimek, Ludger, et al.
Publicado: (2015)

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy
Publicado: (1996)

Determination of IgE and IgG reactivity to more than 170 allergen molecules in paper-dried blood spots
por: Garib, Victoria, et al.
Publicado: (2018)

The History and Science of the Major Birch Pollen Allergen Bet v 1
por: Breiteneder, Heimo, et al.
Publicado: (2023)

Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?
por: Valenta, Rudolf, et al.
Publicado: (2018)

The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals
por: Smole, Ursula, et al.
Publicado: (2015)

Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure
por: Egger, Cornelia, et al.
Publicado: (2015)

Prophylactic and Therapeutic Effects of Oral Immunotherapy on Birch Pollen-Induced Allergic Conjunctivitis in Mice with a Rice-Based Edible Vaccine Expressing a Hypoallergenic Birch Pollen Allergen
por: Ishida, Waka, et al.
Publicado: (2021)

Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 is Isoform Dependent
por: Seutter von Loetzen, Christian, et al.
Publicado: (2015)

Dynamics Rationalize Proteolytic Susceptibility of the Major Birch Pollen Allergen Bet v 1
por: Kamenik, Anna S., et al.
Publicado: (2020)

Recombinant allergens for immunotherapy: state of the art
por: Zhernov, Yury, et al.
Publicado: (2019)

High-Yield Production of the Major Birch Pollen Allergen Bet v 1 With Allergen Immunogenicity in Nicotiana benthamiana
por: Yamada, Yuki, et al.
Publicado: (2020)

The Impact of Nitration on the Structure and Immunogenicity of the Major Birch Pollen Allergen Bet v 1.0101
por: Ackaert, Chloé, et al.
Publicado: (2014)

Stabilization of the Dimeric Birch Pollen Allergen Bet v 1 Impacts Its Immunological Properties
por: Kofler, Stefan, et al.
Publicado: (2014)

Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments
por: Gadermaier, E., et al.
Publicado: (2018)

IgE‐reactivity profiles to allergen molecules in Russian children with and without symptoms of allergy revealed by micro‐array analysis
por: Elisyutina, Olga, et al.
Publicado: (2020)

Binding to Iron Quercetin Complexes Increases the Antioxidant Capacity of the Major Birch Pollen Allergen Bet v 1 and Reduces Its Allergenicity
por: Regner, Andreas, et al.
Publicado: (2022)

Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments
por: Campana, Raffaela, et al.
Publicado: (2015)

Identification of apple cultivars hypoallergenic for birch pollen‐allergic individuals by a multidisciplinary in vitro and in vivo approach
por: Strobl, Maria R., et al.
Publicado: (2022)

Seven different genes encode a diverse mixture of isoforms of Bet v 1, the major birch pollen allergen
por: Schenk, Martijn F, et al.
Publicado: (2006)

Nitration of the Birch Pollen Allergen Bet v 1.0101: Efficiency and Site-Selectivity of Liquid and Gaseous Nitrating Agents
por: Reinmuth-Selzle, Kathrin, et al.
Publicado: (2014)

Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Random mutagenesis and phage display technology as a tool for identifying ige epitopes of the birch pollen allergen Bet v 1
por: Guhsl, Elisabeth Eva, et al.
Publicado: (2014)

Genetic Variants in CHIA and CHI3L1 Are Associated with the IgE Response to the Ascaris Resistance Marker ABA-1 and the Birch Pollen Allergen Bet v 1
por: Acevedo, Nathalie, et al.
Publicado: (2016)

Crystallographically Mapped Ligand Binding Differs in High and Low IgE Binding Isoforms of Birch Pollen Allergen Bet v 1
por: Kofler, Stefan, et al.
Publicado: (2012)

Immunoglobulin E and G4 epitopes of the major allergen of birch pollen Bet v 1 share residues critical for antibody binding
por: Groh, N, et al.
Publicado: (2013)

Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
por: Linhart, B, et al.
Publicado: (2014)

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015)

Highly sensitive ELISA‐based assay for quantification of allergen‐specific IgE antibody levels
por: Karsonova, Antonina, et al.
Publicado: (2020)

High Environmental Ozone Levels Lead to Enhanced Allergenicity of Birch Pollen
por: Beck, Isabelle, et al.
Publicado: (2013)

Comparative proteomics of common allergenic tree pollens of birch, alder, and hazel
por: Darnhofer, Barbara, et al.
Publicado: (2021)

Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
por: Curin, Mirela, et al.
Publicado: (2018)

Top‐down and bottom‐up characterization of nitrated birch pollen allergen Bet v 1a with CZE hyphenated to an Orbitrap mass spectrometer
por: Gusenkov, Sergey, et al.
Publicado: (2018)

Pru du 1, the Bet v 1‐homologue from almond, is a major allergen in patients with birch pollen associated almond allergy
por: Kabasser, Stefan, et al.
Publicado: (2022)

Retinoic acid‐loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice
por: Hufnagl, Karin, et al.
Publicado: (2020)

95 Specific Recognition of the Major Birch Pollen Allergen BET V 1 Programs Dendritic Cells to Induce Either th2 or Tolerogenic Responses
por: Smole, Ursula, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7s8bg7ce1b8vi10j9m5ke5nrp6